Abstract
In a population-based series of 368 children undergoing surgery for medulloblastoma, 304 (83%) survived to complete a course of radiotherapy. Among those patients who completed radiotherapy, the short-term survival rates were lower for young children (those aged under 5 years) than for older children, but by 6 years the survival rates were very similar (approximately 35%) for children in both age groups. Higher survival rates were obtained in the young children where total macroscopic excision of the tumour was achieved. For older children there was no difference in survival rates between those with total or partial excision, though the survival rate was lower for those whose surgery was limited to biopsy. In young children radiotherapy dose had no effect on survival rates. In older children, survival rates were appreciably higher where doses had been at least 45 Gy to the posterior fossa and 30 Gy to the spinal cord, and there were also fewer spinal cord metastases among those who received a higher spinal cord dose. Ninety (30%) of the 304 children also received chemotherapy as part of their initially planned treatment; a wide variety of protocols was used and no conclusions could be drawn as to the effects on survival rates.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berry M. P., Jenkin R. D., Keen C. W., Nair B. D., Simpson W. J. Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg. 1981 Jul;55(1):43–51. doi: 10.3171/jns.1981.55.1.0043. [DOI] [PubMed] [Google Scholar]
- Bloom H. J. Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980. Int J Radiat Oncol Biol Phys. 1982 Jul;8(7):1083–1113. doi: 10.1016/0360-3016(82)90056-6. [DOI] [PubMed] [Google Scholar]
- Bloom H. J. Medulloblastoma in children: increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):2023–2027. doi: 10.1016/0360-3016(82)90466-7. [DOI] [PubMed] [Google Scholar]
- Bloom H. J. Recent concepts in the conservative treatment of intracranial tumours in children. Acta Neurochir (Wien) 1979;50(1-2):103–116. doi: 10.1007/BF01813555. [DOI] [PubMed] [Google Scholar]
- Bloom H. J., Wallace E. N., Henk J. M. The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med. 1969 Jan;105(1):43–62. doi: 10.2214/ajr.105.1.43. [DOI] [PubMed] [Google Scholar]
- Deutsch M. Radiotherapy for primary brain tumors in very young children. Cancer. 1982 Dec 15;50(12):2785–2789. doi: 10.1002/1097-0142(19821215)50:12<2785::aid-cncr2820501216>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
- Gerosa M. A., di Stefano E., Olivi A., Carteri A. Multidisciplinary treatment of medulloblastoma: a 5-year experience with the SIOP trial. Childs Brain. 1981;8(2):107–118. doi: 10.1159/000119972. [DOI] [PubMed] [Google Scholar]
- Wilson L. M., Draper G. J. Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J. 1974 Aug 3;3(5926):301–307. doi: 10.1136/bmj.3.5926.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Eys J., Chen T., Moore T., Cheek W., Sexauer C., Starling K. Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):681–684. [PubMed] [Google Scholar]